Public should have been warned of risk of contracting Ebola at healthcare facilitiesBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2770 (Published 26 May 2015) Cite this as: BMJ 2015;350:h2770
- David Gisselquist, independent researcher and consultant1
- 1PO Box 6758 Kigali, Rwanda
Gericke outlines how the current focus on access to experimental drugs for Ebola virus disease has directed attention away from infection control and the strengthening of health systems.1 Since the first recognised outbreaks of Ebola in 1976,2 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial